Autologous graft cell dose and post-transplant granulocyte colony stimulating factor in post-transplant outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplantation.
Study #: PC20-01
Study Status: Published
Why are higher cd34+ cell doses associated with improved outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors - but not for high-risk neuroblastoma?
Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA.
Journal of Pediatric Hematology/Oncology. 2024, Nov 05: (): . doi: 10.1080/08880018.2024.2420924. Epub 2024, Nov 05. PMCID:.
PMID: 39501613
Abstract